APTORUM GROUP LTD-CLASS A (APM)
KYG6096M1226 - Common Stock
APM gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 561 industry peers in the Biotechnology industry. APM may be in some trouble as it scores bad on both profitability and health. APM has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year APM was profitable.
In the past year APM has reported a negative cash flow from operations.
APM had negative earnings in 4 of the past 5 years.
APM had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
APM has a Return On Assets of 0.11%. This is amongst the best in the industry. APM outperforms 92.43% of its industry peers.
The Return On Equity of APM (0.08%) is better than 93.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.11% | ||
| ROE | 0.08% | ||
| ROIC | N/A |
ROA(3y)-58.32%
ROA(5y)-47.75%
ROE(3y)-59.95%
ROE(5y)-55.8%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for APM so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
APM does not have a ROIC to compare to the WACC, probably because it is not profitable.
APM has more shares outstanding than it did 1 year ago.
The number of shares outstanding for APM has been reduced compared to 5 years ago.
APM has a better debt/assets ratio than last year.
2.2 Solvency
APM has an Altman-Z score of -7.68. This is a bad value and indicates that APM is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -7.68, APM is doing worse than 70.45% of the companies in the same industry.
A Debt/Equity ratio of 0.14 indicates that APM is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.14, APM is doing worse than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -7.68 |
ROIC/WACCN/A
WACC7.5%
2.3 Liquidity
A Current Ratio of 1.17 indicates that APM should not have too much problems paying its short term obligations.
APM's Current ratio of 1.17 is on the low side compared to the rest of the industry. APM is outperformed by 85.05% of its industry peers.
APM has a Quick Ratio of 1.17. This is a normal value and indicates that APM is financially healthy and should not expect problems in meeting its short term obligations.
APM's Quick ratio of 1.17 is on the low side compared to the rest of the industry. APM is outperformed by 83.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.17 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
APM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.48%, which is quite impressive.
APM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.00%.
The Revenue has been growing slightly by 2.57% on average over the past years.
EPS 1Y (TTM)100.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.26%
Revenue 1Y (TTM)-100%
Revenue growth 3Y-22.03%
Revenue growth 5Y2.57%
Sales Q2Q%-100%
3.2 Future
Based on estimates for the next years, APM will show a very strong growth in Earnings Per Share. The EPS will grow by 262.38% on average per year.
APM is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 96.87% yearly.
EPS Next Y86.79%
EPS Next 2Y262.38%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9197.28%
Revenue Next 2Y347.73%
Revenue Next 3Y145.13%
Revenue Next 5Y96.87%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 80.50, the valuation of APM can be described as expensive.
93.51% of the companies in the same industry are more expensive than APM, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.40. APM is valued rather expensively when compared to this.
APM is valuated cheaply with a Price/Forward Earnings ratio of 0.03.
100.00% of the companies in the same industry are more expensive than APM, based on the Price/Forward Earnings ratio.
APM is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.67, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 80.5 | ||
| Fwd PE | 0.03 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
APM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
APM's earnings are expected to grow with 262.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.93
PEG (5Y)N/A
EPS Next 2Y262.38%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for APM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
APTORUM GROUP LTD-CLASS A
NASDAQ:APM (1/6/2025, 8:19:02 PM)
Premarket: 1.66 +0.05 (+3.11%)1.61
-0.53 (-24.77%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners2.06%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap9.03M
Analysts80
Price Target81.6 (4968.32%)
Short Float %0.38%
Short Ratio0.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 80.5 | ||
| Fwd PE | 0.03 | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.4 | ||
| P/tB | 0.4 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.02
EY1.24%
EPS(NY)59.59
Fwd EY3701.24%
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.5
OCFYN/A
SpS0
BVpS4.04
TBVpS4.04
PEG (NY)0.93
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.11% | ||
| ROE | 0.08% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-58.32%
ROA(5y)-47.75%
ROE(3y)-59.95%
ROE(5y)-55.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 0.01% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.17 | ||
| Quick Ratio | 1.17 | ||
| Altman-Z | -7.68 |
F-Score3
WACC7.5%
ROIC/WACCN/A
Cap/Depr(3y)9.25%
Cap/Depr(5y)25.03%
Cap/Sales(3y)8.14%
Cap/Sales(5y)49.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.26%
EPS Next Y86.79%
EPS Next 2Y262.38%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3Y-22.03%
Revenue growth 5Y2.57%
Sales Q2Q%-100%
Revenue Next Year9197.28%
Revenue Next 2Y347.73%
Revenue Next 3Y145.13%
Revenue Next 5Y96.87%
EBIT growth 1Y63.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year96.61%
EBIT Next 3Y58.29%
EBIT Next 5Y49.53%
FCF growth 1Y81.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.01%
OCF growth 3YN/A
OCF growth 5YN/A